Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine maintenance in advanced NSCLC
NCT01797913Phase 2Completed
- Sponsor
- Fudan University
- Start
- Aug 2008
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in non-small cell lung cancer (NSCLC), sponsored by Fudan University. Started Aug 2008; status: completed.
02
Drugs
gemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01797913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01797913.